Report cover image

Monoclonal Antibody Market

Publisher Global Insight Services
Published Oct 16, 2025
Length 376 Pages
SKU # GIS20476390

Description

Monoclonal Antibody Market is anticipated to expand from $251.1 billion in 2024 to $837.4 billion by 2034, growing at a CAGR of approximately 12.8%. The Monoclonal Antibody Market encompasses the development, production, and commercialization of monoclonal antibodies used in diagnostics, therapeutics, and research. These biologics are engineered to target specific antigens, offering precision in treating diseases like cancer, autoimmune disorders, and infectious diseases. The market is driven by advancements in biotechnology, increasing prevalence of chronic diseases, and the demand for personalized medicine, positioning it as a pivotal segment in the biopharmaceutical industry.

Segment Overview

The Monoclonal Antibody Market is experiencing robust growth, propelled by advancements in biotechnology and increasing therapeutic applications. The oncology segment is the top-performing sub-segment, driven by the rising incidence of cancer and the efficacy of monoclonal antibodies in targeted therapies. Immunology follows as the second highest-performing segment, benefiting from increased research and development in autoimmune and inflammatory diseases. Within the oncology segment, checkpoint inhibitors and growth factor receptor inhibitors are leading the charge, showcasing significant clinical success and adoption.

In the immunology sub-segment, TNF inhibitors and interleukin inhibitors are prominent, addressing a wide range of conditions such as rheumatoid arthritis and psoriasis. The biosimilars segment is also gaining momentum, offering cost-effective alternatives and expanding access to treatment. Innovations in antibody-drug conjugates are further enhancing therapeutic outcomes, presenting lucrative opportunities for market players. Collaborations between pharmaceutical companies and research institutions are fostering novel developments, ensuring sustained growth and competitive advantage in the market.

Key Trends and Drivers

The monoclonal antibody market is experiencing robust growth, propelled by advancements in biotechnology and genetic engineering. The rising prevalence of chronic diseases, such as cancer and autoimmune disorders, is a significant driver, increasing the demand for targeted therapies. Monoclonal antibodies offer precision treatment options, minimizing adverse effects and improving patient outcomes. The market is further fueled by increased investments in research and development by pharmaceutical companies. Innovations in antibody-drug conjugates and bispecific antibodies are enhancing therapeutic efficacy, creating lucrative opportunities. Regulatory approvals for novel monoclonal antibodies are accelerating, boosting market expansion. Moreover, the COVID-19 pandemic has underscored the importance of monoclonal antibodies in infectious disease management, driving their adoption in new therapeutic areas. The trend towards personalized medicine is also shaping the market, as monoclonal antibodies can be tailored to individual patient needs. With a strong pipeline of products and strategic collaborations, the monoclonal antibody market is poised for sustained growth.

Key Players

BioXcel Therapeutics, Aptevo Therapeutics, Argenx, MacroGenics, ImmunoGen, Xencor, Cellectis, MorphoSys, Alligator Bioscience, Genmab, AbCellera, Kymab, Tiziana Life Sciences, Harpoon Therapeutics, Crescendo BiologicsResearch Scope
  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.
Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

Please Note: This report will be delivered by publisher within 2-3 business days of order confirmation.

Table of Contents

376 Pages
Monoclonal Antibody Market Overview
Chapter 1
Sections: 1.1 Objectives of the Study
1.2 Monoclonal Antibody Market Definition and Scope of the Report
1.3 Report Limitations
1.4 Years & Currency Considered in the Study
1.5 Research Methodologies
1.5.1 Secondary Research
1.5.2 Primary Research
1.5.3 Market Size Estimation: Top-Down Approach
1.5.4 Market Size Estimation: Bottom-Up Approach
1.5.5 Data Triangulation and Validation
Executive Summary
Chapter 2
Sections: 2.1 Summary
2.2 Key Opinion Leaders
2.3 Key Highlights of the Market, by Type
2.4 Key Highlights of the Market, by Product
2.5 Key Highlights of the Market, by Application
2.6 Key Highlights of the Market, by Technology
2.7 Key Highlights of the Market, by End User
2.8 Key Highlights of the Market, by Process
2.9 Key Highlights of the Market, by Services
2.10 Key Highlights of the Market, by Form
2.11 Key Highlights of the Market, by Deployment
2.12 Key Highlights of the Market, by Mode
2.13 Key Highlights of the Market, by North America
2.14 Key Highlights of the Market, by Europe
2.15 Key Highlights of the Market, by Asia-Pacific
2.16 Key Highlights of the Market, by Latin America
2.17 Key Highlights of the Market, by Middle East
2.18 Key Highlights of the Market, by Africa
Premium Insights on the Market
Chapter 3
Sections: 3.1 Market Attractiveness Analysis, by Region
3.2 Market Attractiveness Analysis, by Type
3.3 Market Attractiveness Analysis, by Product
3.4 Market Attractiveness Analysis, by Application
3.5 Market Attractiveness Analysis, by Technology
3.6 Market Attractiveness Analysis, by End User
3.7 Market Attractiveness Analysis, by Process
3.8 Market Attractiveness Analysis, by Services
3.9 Market Attractiveness Analysis, by Form
3.10 Market Attractiveness Analysis, by Deployment
3.11 Market Attractiveness Analysis, by Mode
3.12 Market Attractiveness Analysis, by North America
3.13 Market Attractiveness Analysis, by Europe
3.14 Market Attractiveness Analysis, by Asia-Pacific
3.15 Market Attractiveness Analysis, by Latin America
3.16 Market Attractiveness Analysis, by Middle East
3.17 Market Attractiveness Analysis, by Africa
Monoclonal Antibody Market Outlook
Chapter 4
Sections: 4.1 Monoclonal Antibody Market Segmentation
4.2 Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Trends
4.2.3 Market Restraints
4.2.4 Market Opportunities
4.3 Porters Five Forces Analysis
4.3.1 Threat of New Entrants
4.3.2 Threat of Substitutes
4.3.3 Bargaining Power of Buyers
4.3.4 Bargaining Power of Supplier
4.3.5 Competitive Rivalry
4.4 PESTLE Analysis
4.5 Value Chain Analysis
4.6 4Ps Model
4.7 ANSOFF Matrix
Monoclonal Antibody Market Strategy
Chapter 5
Sections: 5.1 Parent Market Analysis
5.2 Supply-Demand Analysis
5.3 Consumer Buying Interest
5.4 Case Study Analysis
5.5 Pricing Analysis
5.6 Regulatory Landscape
5.7 Supply Chain Analysis
5.8 Competition Product Analysis
5.9 Recent Developments
Monoclonal Antibody Market Size
Chapter 6
Sections: 6.1 Monoclonal Antibody Market Size, by Value
6.2 Monoclonal Antibody Market Size, by Volume
Monoclonal Antibody Market, by Type
Chapter 7
Sections: 7.1 Market Overview
7.2 Murine
7.2.1 Key Market Trends & Opportunity Analysis
7.2.2 Market Size and Forecast, by Region
7.3 Chimeric
7.3.1 Key Market Trends & Opportunity Analysis
7.3.2 Market Size and Forecast, by Region
7.4 Humanized
7.4.1 Key Market Trends & Opportunity Analysis
7.4.2 Market Size and Forecast, by Region
7.5 Human
7.5.1 Key Market Trends & Opportunity Analysis
7.5.2 Market Size and Forecast, by Region
7.6 Bispecific
7.6.1 Key Market Trends & Opportunity Analysis
7.6.2 Market Size and Forecast, by Region
7.7 Conjugated
7.7.1 Key Market Trends & Opportunity Analysis
7.7.2 Market Size and Forecast, by Region
7.8 Polyclonal
7.8.1 Key Market Trends & Opportunity Analysis
7.8.2 Market Size and Forecast, by Region
7.9 Monoclonal
7.9.1 Key Market Trends & Opportunity Analysis
7.9.2 Market Size and Forecast, by Region
7.10 Others
7.10.1 Key Market Trends & Opportunity Analysis
7.10.2 Market Size and Forecast, by Region
Monoclonal Antibody Market, by Product
Chapter 8
Sections: 8.1 Market Overview
8.2 Therapeutic Antibodies
8.2.1 Key Market Trends & Opportunity Analysis
8.2.2 Market Size and Forecast, by Region
8.3 Diagnostic Antibodies
8.3.1 Key Market Trends & Opportunity Analysis
8.3.2 Market Size and Forecast, by Region
8.4 Research Antibodies
8.4.1 Key Market Trends & Opportunity Analysis
8.4.2 Market Size and Forecast, by Region
8.5 Custom Antibodies
8.5.1 Key Market Trends & Opportunity Analysis
8.5.2 Market Size and Forecast, by Region
8.6 Others
8.6.1 Key Market Trends & Opportunity Analysis
8.6.2 Market Size and Forecast, by Region
Monoclonal Antibody Market, by Application
Chapter 9
Sections: 9.1 Market Overview
9.2 Oncology
9.2.1 Key Market Trends & Opportunity Analysis
9.2.2 Market Size and Forecast, by Region
9.3 Autoimmune Diseases
9.3.1 Key Market Trends & Opportunity Analysis
9.3.2 Market Size and Forecast, by Region
9.4 Infectious Diseases
9.4.1 Key Market Trends & Opportunity Analysis
9.4.2 Market Size and Forecast, by Region
9.5 Neurology
9.5.1 Key Market Trends & Opportunity Analysis
9.5.2 Market Size and Forecast, by Region
9.6 Cardiovascular Diseases
9.6.1 Key Market Trends & Opportunity Analysis
9.6.2 Market Size and Forecast, by Region
9.7 Inflammatory Diseases
9.7.1 Key Market Trends & Opportunity Analysis
9.7.2 Market Size and Forecast, by Region
9.8 Transplantation
9.8.1 Key Market Trends & Opportunity Analysis
9.8.2 Market Size and Forecast, by Region
9.9 Hematology
9.9.1 Key Market Trends & Opportunity Analysis
9.9.2 Market Size and Forecast, by Region
9.10 Others
9.10.1 Key Market Trends & Opportunity Analysis
9.10.2 Market Size and Forecast, by Region
Monoclonal Antibody Market, by Technology
Chapter 10
Sections: 10.1 Market Overview
10.2 Hybridoma Technology
10.2.1 Key Market Trends & Opportunity Analysis
10.2.2 Market Size and Forecast, by Region
10.3 Phage Display
10.3.1 Key Market Trends & Opportunity Analysis
10.3.2 Market Size and Forecast, by Region
10.4 Transgenic Mice
10.4.1 Key Market Trends & Opportunity Analysis
10.4.2 Market Size and Forecast, by Region
10.5 Bacterial Display
10.5.1 Key Market Trends & Opportunity Analysis
10.5.2 Market Size and Forecast, by Region
10.6 Yeast Display
10.6.1 Key Market Trends & Opportunity Analysis
10.6.2 Market Size and Forecast, by Region
10.7 Single B Cell Amplification
10.7.1 Key Market Trends & Opportunity Analysis
10.7.2 Market Size and Forecast, by Region
10.8 Others
10.8.1 Key Market Trends & Opportunity Analysis
10.8.2 Market Size and Forecast, by Region
Monoclonal Antibody Market, by End User
Chapter 11
Sections: 11.1 Market Overview
11.2 Hospitals
11.2.1 Key Market Trends & Opportunity Analysis
11.2.2 Market Size and Forecast, by Region
11.3 Research Institutes
11.3.1 Key Market Trends & Opportunity Analysis
11.3.2 Market Size and Forecast, by Region
11.4 Biopharmaceutical Companies
11.4.1 Key Market Trends & Opportunity Analysis
11.4.2 Market Size and Forecast, by Region
11.5 Diagnostic Laboratories
11.5.1 Key Market Trends & Opportunity Analysis
11.5.2 Market Size and Forecast, by Region
11.6 Contract Research Organizations
11.6.1 Key Market Trends & Opportunity Analysis
11.6.2 Market Size and Forecast, by Region
11.7 Others
11.7.1 Key Market Trends & Opportunity Analysis
11.7.2 Market Size and Forecast, by Region
Monoclonal Antibody Market, by Process
Chapter 12
Sections: 12.1 Market Overview
12.2 In Vivo
12.2.1 Key Market Trends & Opportunity Analysis
12.2.2 Market Size and Forecast, by Region
12.3 In Vitro
12.3.1 Key Market Trends & Opportunity Analysis
12.3.2 Market Size and Forecast, by Region
12.4 In Silico
12.4.1 Key Market Trends & Opportunity Analysis
12.4.2 Market Size and Forecast, by Region
12.5 Others
12.5.1 Key Market Trends & Opportunity Analysis
12.5.2 Market Size and Forecast, by Region
Monoclonal Antibody Market, by Services
Chapter 13
Sections: 13.1 Market Overview
13.2 Antibody Production
13.2.1 Key Market Trends & Opportunity Analysis
13.2.2 Market Size and Forecast, by Region
13.3 Antibody Engineering
13.3.1 Key Market Trends & Opportunity Analysis
13.3.2 Market Size and Forecast, by Region
13.4 Antibody Labeling
13.4.1 Key Market Trends & Opportunity Analysis
13.4.2 Market Size and Forecast, by Region
13.5 Antibody Purification
13.5.1 Key Market Trends & Opportunity Analysis
13.5.2 Market Size and Forecast, by Region
13.6 Antibody Fragmentation
13.6.1 Key Market Trends & Opportunity Analysis
13.6.2 Market Size and Forecast, by Region
13.7 Others
13.7.1 Key Market Trends & Opportunity Analysis
13.7.2 Market Size and Forecast, by Region
Monoclonal Antibody Market, by Form
Chapter 14
Sections: 14.1 Market Overview
14.2 Liquid
14.2.1 Key Market Trends & Opportunity Analysis
14.2.2 Market Size and Forecast, by Region
14.3 Lyophilized
14.3.1 Key Market Trends & Opportunity Analysis
14.3.2 Market Size and Forecast, by Region
14.4 Others
14.4.1 Key Market Trends & Opportunity Analysis
14.4.2 Market Size and Forecast, by Region
Monoclonal Antibody Market, by Deployment
Chapter 15
Sections: 15.1 Market Overview
15.2 In-house
15.2.1 Key Market Trends & Opportunity Analysis
15.2.2 Market Size and Forecast, by Region
15.3 Outsourced
15.3.1 Key Market Trends & Opportunity Analysis
15.3.2 Market Size and Forecast, by Region
15.4 Others
15.4.1 Key Market Trends & Opportunity Analysis
15.4.2 Market Size and Forecast, by Region
Monoclonal Antibody Market, by Mode
Chapter 16
Sections: 16.1 Market Overview
16.2 Therapeutic
16.2.1 Key Market Trends & Opportunity Analysis
16.2.2 Market Size and Forecast, by Region
16.3 Prophylactic
16.3.1 Key Market Trends & Opportunity Analysis
16.3.2 Market Size and Forecast, by Region
16.4 Others
16.4.1 Key Market Trends & Opportunity Analysis
16.4.2 Market Size and Forecast, by Region

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us